Latest Antifungal medication Stories
HedgePath to shortly commence Phase II(b) skin cancer trial using Mayne Pharma's SUBA(TM)-Itraconazole TAMPA, Fla.
NORTHBROOK, Ill., April 27, 2015 /PRNewswire/ -- Astellas announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, is now available in the United States
DALLAS, April 20, 2015 /PRNewswire/ -- MarketReportsOnline.com adds "Global Antifungal Therapeutics Market" research report to the Pharmaceuticals segment of its online
NORTHBROOK, Ill., March 6, 2015 /PRNewswire/ -- Astellas today announced that the U.S.
Dermatology Specialists Dr. Joshua Fox and Dr.
Cinnamon oil has been valued throughout history for its natural medicinal benefits.
Company plans to commence clinical development of SUBA®-Itraconazole for treatment of basal cell carcinoma in patients with basal cell carcinoma nevus syndrome TAMPA, Fla.
MarketReportsOnline.com adds "Global Antifungal Therapeutics Market:Trends and Opportunities (2014-2019)" report to its research store. Dallas, Texas
- The parings of haberdine; also, any kind of fragments.